arrow
M

Michael Weller

University Hospital Zurich
H指数:175
被引数:16.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent genomic evolution in astrocytomas and oligodendrogliomas

星形胶质瘤和少突胶质瘤的基因组趋异进化

Nature
IF48.5
2026-10-140
OAAI
Proteomic-guided targeted treatment of leukoencephalopathy with calcification and cysts

基于蛋白质组学的靶向治疗伴有钙化和囊肿的白质脑病

Brain
IF11.7
2026-09-110
OAAI
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma

替莫唑胺相关血液学毒性与新诊断胶质母细胞瘤患者健康相关生活质量(HRQoL)的关联

2026-09-080
PRE
Spatial analysis reveals the evolving organization of IDH-mutant glioma

空间分析揭示了IDH突变型胶质瘤的演变组织

2026-09-010
PRE
18 TTFields with maintenance temozolomide/pembrolizumab versus TTFields with maintenance temozolomide/placebo for newly diagnosed glioblastoma: the phase 3 EF-41/KEYNOTE D58 trial

替莫唑胺/帕博利珠单抗维持治疗联合TTFields与替莫唑胺/安慰剂维持治疗联合TTFields治疗新诊断胶质母细胞瘤:EF-41/KEYNOTE D58三期临床试验

2026-08-270
OAAI
ESTRO, ESNR, and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumors

ESTRO、ESNR和EORTC基于共识的颅内中枢神经系统肿瘤放疗后MRI异常定义

2026-08-200
PRE
Hypoxia-targeted BOLD MRI signal heterogeneity as a complementary metric for glioblastoma characterization: a pilot study

乏氧靶向BOLD MRI信号异质性作为胶质母细胞瘤表征的补充指标:一项试点研究

2026-08-200
OA
TPRG-04 ETOP 19-21 USZ-STRIKE: IMMUNOTHERAPY OR TARGETED THERAPY WITH OR WITHOUT STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH BRAIN METASTASES FROM MELANOMA OR NON-SMALL CELL LUNG CANCER

TPRG-04 ETOP 19-21 USZ-STRIKE:针对黑色素瘤或非小细胞肺癌脑转移患者的免疫治疗或靶向治疗,联合或不联合立体定向放射外科

2026-08-070
OA
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma

少突胶质细胞瘤患者对卡莫司汀和CCNU联合化疗的放射学反应模式

2026-08-060
OA
Spinal high-grade astrocytoma with piloid features presenting with progressive encephalopathy, hypoglycorrhachia, hydrocephalus, and leptomeningeal dissemination

伴有进行性脑病、低糖炎性脑脊液、脑积水及软脑膜播散的具有Piloid特征的脊柱高级别星形细胞瘤

2026-07-140
PRE
Decision-Making in Intrathecal Therapy for Leptomeningeal Disease

脑膜癌病鞘内治疗中的决策制定

2026-05-010
PRE
Consensus statement on microglial and macrophage functions in gliomas

关于小胶质细胞和巨噬细胞在胶质瘤中功能的一致性声明

2026-04-160
OAAI
CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)

VORASIDENIB CTNI-09作为IDH突变2/3级星形细胞瘤一线放化疗后的维持治疗: 安慰剂对照,三盲,随机III期研究EORTC-2427 (VIGOR) 的研究方案

2025-11-110
OA